Fulgent Genetics, Inc.
FLGT
$14.82
$0.191.30%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -41.69% | 73.94% | 68.78% | 75.43% | 74.55% |
| Total Depreciation and Amortization | -3.23% | -4.22% | -6.53% | -6.72% | -4.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.69% | -69.46% | -65.48% | -71.77% | -72.22% |
| Change in Net Operating Assets | -1,525.00% | -125.34% | -4,290.59% | -274.92% | -354.80% |
| Cash from Operations | -582.61% | -86.12% | -168.33% | -77.80% | -22.01% |
| Capital Expenditure | 44.01% | 46.09% | -39.27% | -69.12% | -81.54% |
| Sale of Property, Plant, and Equipment | -98.40% | -99.23% | -93.67% | -93.17% | -59.61% |
| Cash Acquisitions | -- | 1,046.12% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 809.35% | 175.75% | 233.14% | 189.46% | -130.22% |
| Cash from Investing | 290.86% | 1,197.96% | 1,303.11% | 521.02% | -250.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 50.96% | 74.59% | 81.55% | 92.84% | 91.13% |
| Issuance of Common Stock | -98.04% | -- | -- | 1,600.00% | 1,600.00% |
| Repurchase of Common Stock | -345.58% | 48.94% | 52.68% | 59.13% | 88.76% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -205.12% | 52.14% | 57.23% | 73.30% | 89.86% |
| Foreign Exchange rate Adjustments | 290.91% | -146.43% | 177.55% | 110.16% | 63.09% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 88.27% | 330.12% | 238.67% | 210.82% | -334.84% |